The global High Throughput Process DevelopmentMarketwas valued at USD 162.78 million in 2016 and is projected to reach USD 623.88million by 2025, growing at a CAGR of 14.38% from 2017 to 2025.
HTPD involves chromatography techniques which help in better and accurate result prediction and analysis. With increasing availability of funds and investment by Govt. and Private sector both, the R&D sector is expected to boost the market for the technique in the coming years.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Rising R&D Spending
1.2 Technological Advancements in Process Development
1.3 Growth in the Biopharmaceutical Industry
1.4 Growing Pressure to Lower the Cost of Manufacturing
2. Market Restraints
2.1 High Cost of Advanced Technologies and Lack of Adequate Infrastructural Facilities
Market Segmentation:
1. Global High Throughput Process DevelopmentMarket, by Product and services:
1.1 Services
1.2 Software
1.3 Instruments
1.3.1 Automated Integrated Workstation
1.3.2 Automated Miniature Bioreactor System
1.4 Consumables
1.4.1 Miniature Prepacked Columns
1.4.2 Microtiter Plates
1.4.3 Miniaturized Disposable Bioreactor
1.4.4 Micropipettes and Pipette Tips
1.4.5 Other Consumables
2. Global High Throughput Process DevelopmentMarket, by Molecule Type:
2.1 Monoclonal Antibodies
2.2 Other Molecules
3. Global High Throughput Process DevelopmentMarket, by Technology:
3.1 Chromatography
3.1.1 Affinity Chromatography
3.1.2 Ion-Exchange Chromatography
3.1.3 Multimodal Chromatography
3.1.4 Other Chromatography
3.2 Ultraviolet-Visible Spectroscopy
3.3 Other Technologies
4. Global High Throughput Process Development Market, by End User:
4.1 Biopharmaceutical
4.2 Contract Research Organization
4.3 Academic Research Institutes
5. Global High Throughput Process Development Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Danaher Corporation
2. GE Healthcare
3. Thermo Fisher Scientific Inc.
4. Merck Millipore
5. Agilent Technologies
6. Bio-Rad Laboratories
7. Eppendorf
8. Perkinelmer
9. Sartorius Stedim Biotech
10. Tecan Group
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the High Throughput Process DevelopmentMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL HIGH THROUGHPUT PROCESS DEVELOPMENTMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL HIGH THROUGHPUT PROCESS DEVELOPMENTMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL HIGH THROUGHPUT PROCESS DEVELOPMENT MARKET, BY PRODUCT AND SERVICES
5.1 Services
5.2 Software
5.3 Instruments
5.3.1 Automated Integrated Workstation
5.3.2 Automated Miniature Bioreactor System
5.4 Consumables
5.4.1 Miniature Prepacked Columns
5.4.2 Microtiter Plates
5.4.3 Miniaturized Disposable Bioreactor
5.4.4 Micropipettes and Pipette Tips
5.4.5 Other Consumables
6 GLOBAL HIGH THROUGHPUT PROCESS DEVELOPMENT MARKET, BY MOLECULE TYPE
6.1 Monoclonal Antibodies
6.2 Other Molecules
7 GLOBAL HIGH THROUGHPUT PROCESS DEVELOPMENT MARKET, BY TECHNOLOGY
7.1 Chromatography
7.1.1 Affinity Chromatography
7.1.2 Ion-Exchange Chromatography
7.1.3 Multimodal Chromatography
7.1.4 Other Chromatography
7.2 Ultraviolet-Visible Spectroscopy
7.3 Other Technologies
8 GLOBAL HIGH THROUGHPUT PROCESS DEVELOPMENT MARKET, BY END USER
8.1 Biopharmaceutical
8.2 Contract Research Organization
8.3 Academic Research Institutes
9 GLOBAL HIGH THROUGHPUT PROCESS DEVELOPMENTMARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
10 GLOBAL HIGH THROUGHPUT PROCESS DEVELOPMENTMARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Danaher Corporation
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 GE Healthcare
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Thermo Fisher Scientific Inc.
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Merck Millipore
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Agilent Technologies
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Bio-Rad Laboratories
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Eppendorf
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Perkinelmer
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Sartorius Stedim Biotech
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Tecan Group
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
12 Appendix
12.1 Related Reports
Price : US$ 3500 |
Date : Nov 2024 |
Category : Services |
Pages : 119 |